Posted by Michael Wonder on 30 Oct 2023
Expanded access to chronic heart failure treatment on the PBS
30 October 2023 - More Australians with chronic heart failure will have access to subsidised treatment under the PBS.
From 1 November 2023, empagliflozin (Jardiance) will be expanded to treat chronic heart failure in patients with a left ventricular ejection fraction greater than 40%.
